Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Pick Up Shares on Weakness
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Cepheid (NASDAQ: CPHD) price target of $50.00.
Analyst, Jeffrey Frelick, said, "We reiterate our BUY as CPHD demonstrates that the GeneXpert system continues to be the molecular instrument of choice. Despite 300bps of one-time negative impacts to GM, CPHD recorded the largest sequential reagent growth in its history."
For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.
Shares of Cepheid closed at $40.58 yesterday.
Analyst, Jeffrey Frelick, said, "We reiterate our BUY as CPHD demonstrates that the GeneXpert system continues to be the molecular instrument of choice. Despite 300bps of one-time negative impacts to GM, CPHD recorded the largest sequential reagent growth in its history."
For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.
Shares of Cepheid closed at $40.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- UBS Reiterates Buy Rating on HF Sinclair (DINO)
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
